SCM
SION

Sterling Capital Management’s Sionna Therapeutics SION Stock Holding History

Sterling Capital Management’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.86K Sell
65
-40
-38% -$1.6K ﹤0.01% 2891
2026
Q1 		$4.21K Hold
105
– – ﹤0.01% 2801
2025
Q4 		$4.32K Buy
105
+75
+250% +$2.84K ﹤0.01% 2934
2025
Q3 		$882 Hold
30
– – ﹤0.01% 3097
2025
Q2 		$521 Buy
+30
New +$393 ﹤0.01% 3150

Other funds holding SION

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Sterling Capital Management's SION Position: Q2 2026 in Review

Sterling Capital Management reduced its Sionna Therapeutics (SION) stake by 38% in Q2 2026, selling an estimated $1.6K and leaving 65 shares worth $2.86K. The position accounts for ﹤0.01% of the portfolio, ranked #2891.

Sterling Capital Management first reported a position in SION in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.32K in Q4 2025. 17 funds tracked by Wall St. Rank hold SION as of Q2 2026.

  • Sterling Capital Management held 65 shares of Sionna Therapeutics worth $2.86K as of Q2 2026.
  • Sterling Capital Management sold 40 Sionna Therapeutics shares in Q2 2026, an estimated $1.6K.
  • Sionna Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2891 holding.
  • Sterling Capital Management first reported a position in Sionna Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Sterling Capital Management's Sionna Therapeutics position peaked at $4.32K in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.